These effects, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 guidance the notion of focusing on ACKR3 as a novel solution to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated Diseases. All of our information https://manueliokmy.theideasblog.com/26777718/5-easy-facts-about-conolidine-described